The Experts below are selected from a list of 303 Experts worldwide ranked by ideXlab platform
Bernd Löwe - One of the best experts on this subject based on the ideXlab platform.
-
development and validation of the somatic Symptom disorder b criteria scale ssd 12
Psychosomatic Medicine, 2016Co-Authors: Annekristin Toussaint, Benjamin Gierk, Katharina Voigt, Annabel Herzog, Alexandra M. Murray, Kurt Kroenke, Winfried Rief, Peter Henningsen, Bernd LöweAbstract:To develop and validate a new self-report questionnaire for the assessment of the Psychological features of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition somatic Symptom disorder.The Somatic Symptom Disorder-B Criteria Scale (SSD-12) was developed in several steps from an initial pool of 98 items. The SSD-12 is composed of 12 items; each of the three Psychological subcriteria is measured by four items. In a cross-sectional study, the SSD-12 was administered to 698 patients (65.8% female, mean [standard deviation] age = 38.79 [14.15] years) from a psychosomatic outpatient clinic. Item and scale characteristics as well as measures of reliability and validity were determined.The SSD-12 has good item characteristics and excellent reliability (Cronbach α =.95). Confirmatory factor analyses suggested that a three-factorial structure that reflects the three Psychological criteria interpreted as cognitive, affective, and behavioral aspects (n = 663, Comparative Fit Index > 0.99, Tucker-Lewis Index > 0.99, Root Mean Square Error of Approximation = 0.06, 90% confidence interval = 0.01-0.08). SSD-12 total sum score was significantly associated with somatic Symptom burden (r = 0.47, p <.001) and health anxiety (r = 0.71, p <.001), and moderately associated with general anxiety (r = 0.35, p <.001) and depressive Symptoms (r = 0.22, p <.001). Patients with a higher SSD-12 Psychological Symptom burden reported higher general physical and mental health impairment and significantly higher health care use.The SSD-12 is the first self-report questionnaire that operationalizes the new Psychological characteristics of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition somatic Symptom disorder. Initial assessment indicates that the SSD-12 has sufficient reliability and validity to warrant further testing in both research and clinical settings.
-
towards positive diagnostic criteria a systematic review of somatoform disorder diagnoses and suggestions for future classification
Journal of Psychosomatic Research, 2010Co-Authors: Katharina Voigt, Annabel Nagel, Bjorn Meyer, Gernot Langs, Christoph Braukhaus, Bernd LöweAbstract:Abstract Objectives The classification of somatoform disorders is currently being revised in order to improve its validity for the DSM-V and ICD-11 . In this article, we compare the validity and clinical utility of current and several new diagnostic proposals of those somatoform disorders that focus on medically unexplained somatic Symptoms. Methods We searched the Medline, PsycInfo, and Cochrane databases, as well as relevant reference lists. We included review papers and original articles on the subject of somatoform classification in general, subtypes of validity of the diagnoses, or single diagnostic criteria. Results Of all diagnostic proposals, only complex somatic Symptom disorder and the Conceptual Issues in Somatoform and Similar Disorders (CISSD) example criteria reflect all dimensions of current biopsychosocial models of somatization ( construct validity ) and go beyond somatic Symptom counts by including Psychological and behavioral Symptoms that are specific to somatization ( descriptive validity ). Predictive validity of most of the diagnostic proposals has not yet been investigated. However, the number of somatic Symptoms has been found to be a strong predictor of disability. Some evidence indicates that Psychological Symptoms can predict disease course and treatment outcome (e.g., therapeutic modification of catastrophizing is associated with positive outcome). Lengthy Symptom lists, the requirement of lifetime Symptom report (as in abridged somatization), complicated Symptom patterns (as in current somatization disorder), and imprecise definitions of diagnostic procedures (e.g., missing Symptom threshold in complex somatic Symptom disorder) reduce clinical utility . Conclusion Results from the reviewed studies suggest that, of all current and new diagnostic suggestions, complex somatic Symptom disorder and the CISSD definition appear to have advantages regarding validity and clinical utility. The integration of Psychological and behavioral criteria could enhance construct and descriptive validity, and confers prospectively relevant treatment implications. The incorporation of a dimensional approach that reflects both somatic and Psychological Symptom severity also has the potential to improve predictive validity and clinical utility.
Kurt Kroenke - One of the best experts on this subject based on the ideXlab platform.
-
comprehensive vs assisted management of mood and pain Symptoms cammps trial study design and sample characteristics
Contemporary Clinical Trials, 2018Co-Authors: Kurt Kroenke, Erica Evans, Sharon Weitlauf, Stephanie Mccalley, Brian Porter, Tabeel Williams, Fitsum Baye, Spencer Lourens, Marianne S MatthiasAbstract:Abstract Background Pain is the most common presenting somatic Symptom in medical outpatients, and depression and anxiety are the two most common mental disorders. They frequently co-occur, are under-treated, and result in substantial disability and reduced health-related quality of life. Objectives The Comprehensive vs. Assisted Management of Mood and Pain Symptoms ( CAMMPS ) study is a randomized comparative effectiveness trial designed to test the relative effectiveness of a lower-resource vs. a higher-resource technology-assisted intervention for the management of patients suffering from pain plus anxiety and/or depression. Methods/design CAMMPS has enrolled 294 primary care patients with chronic pain plus comorbid anxiety and/or depression and randomized them to either: 1) Assisted Symptom Management (ASM) consisting of automated Symptom monitoring by interactive voice recording or Internet and prompted pain and mood self-management; or 2) Comprehensive Symptom Management (CSM) which combines ASM with optimized medication management delivered by a nurse-physician specialist team and facilitated mental health care. Outcomes are assessed at baseline, 1, 3, 6, and 12 months. The primary outcome is a composite pain-anxiety-depression (PAD) severity score. Secondary outcomes include individual pain, anxiety, and depression scores, health-related quality of life, disability, healthcare utilization, and treatment satisfaction. Discussion CAMMPS provides an integrated approach to PAD Symptoms rather than fragmented care of single Symptoms; coordinated Symptom management in partnership with primary care clinicians and psychologists embedded in primary care; efficient use of health information technology; attention to physical and Psychological Symptom comorbidity; and the coupling of self-management with optimized medication management and facilitated mental health care. Trial registration clinicaltrials.gov Identifier: NCT01757301 .
-
development and validation of the somatic Symptom disorder b criteria scale ssd 12
Psychosomatic Medicine, 2016Co-Authors: Annekristin Toussaint, Benjamin Gierk, Katharina Voigt, Annabel Herzog, Alexandra M. Murray, Kurt Kroenke, Winfried Rief, Peter Henningsen, Bernd LöweAbstract:To develop and validate a new self-report questionnaire for the assessment of the Psychological features of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition somatic Symptom disorder.The Somatic Symptom Disorder-B Criteria Scale (SSD-12) was developed in several steps from an initial pool of 98 items. The SSD-12 is composed of 12 items; each of the three Psychological subcriteria is measured by four items. In a cross-sectional study, the SSD-12 was administered to 698 patients (65.8% female, mean [standard deviation] age = 38.79 [14.15] years) from a psychosomatic outpatient clinic. Item and scale characteristics as well as measures of reliability and validity were determined.The SSD-12 has good item characteristics and excellent reliability (Cronbach α =.95). Confirmatory factor analyses suggested that a three-factorial structure that reflects the three Psychological criteria interpreted as cognitive, affective, and behavioral aspects (n = 663, Comparative Fit Index > 0.99, Tucker-Lewis Index > 0.99, Root Mean Square Error of Approximation = 0.06, 90% confidence interval = 0.01-0.08). SSD-12 total sum score was significantly associated with somatic Symptom burden (r = 0.47, p <.001) and health anxiety (r = 0.71, p <.001), and moderately associated with general anxiety (r = 0.35, p <.001) and depressive Symptoms (r = 0.22, p <.001). Patients with a higher SSD-12 Psychological Symptom burden reported higher general physical and mental health impairment and significantly higher health care use.The SSD-12 is the first self-report questionnaire that operationalizes the new Psychological characteristics of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition somatic Symptom disorder. Initial assessment indicates that the SSD-12 has sufficient reliability and validity to warrant further testing in both research and clinical settings.
-
reciprocal relationship between pain and depression a 12 month longitudinal analysis in primary care
The Journal of Pain, 2011Co-Authors: Kurt Kroenke, Matthew J Bair, Erin E Krebs, Teresa M DamushAbstract:Abstract Pain and depression are the most prevalent physical and Psychological Symptom-based disorders, respectively, and co-occur 30 to 50% of the time. However, their reciprocal relationship and potentially causative effects on one another have been inadequately studied. Longitudinal data analysis involving 500 primary care patients with persistent back, hip, or knee pain were enrolled in the Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study. Half of the participants had comorbid depression and were randomized to a stepped care intervention (n = 123) or treatment as usual (n = 127). Another 250 nondepressed patients with similar pain were followed in a parallel cohort. Outcomes were assessed at baseline, 3, 6, and 12 months. Mixed effects model repeated measures (MMRM) multivariable analyses were conducted to determine if change in pain severity predicted subsequent depression severity, and vice versa. Change in pain was a strong predictor of subsequent depression severity (t-value = 6.63, P P Perspective This study strengthens the evidence for a bidirectional and potentially causative influence of pain and depression on one another. A change in severity of either Symptom predicts subsequent severity of the other Symptom. Thus, recognition and management of both conditions may be warranted, particularly when treatment focused on 1 condition is not leading to an optimal response.
Camilla Zimmermann - One of the best experts on this subject based on the ideXlab platform.
-
the association of physical and Psychological Symptom burden with time to death among palliative cancer outpatients
Journal of Pain and Symptom Management, 2009Co-Authors: Winson Y Cheung, Niusha Barmala, Sanaz Zarinehbaf, Gary Rodin, Lisa W Le, Camilla ZimmermannAbstract:Abstract Previous studies have reported on the Symptom burden of cancer inpatients, but outpatient studies have been few and have not examined the association of Symptoms with time to death (TTD). Cancer patients seen in an oncology palliative care clinic from January 2005 to June 2006 and who subsequently died were identified from a palliative care database. Data from the last outpatient Edmonton Symptom Assessment Scale (ESAS) score completed in clinic were analyzed among patients who were followed during the last four months of life. Multiple linear regression analyses with Bonferroni adjustment were used to determine the association of ESAS total Symptom distress score (TSDS), physical subscore (PHS), Psychological subscore (PSS), and individual Symptom scores with demographic parameters, disease characteristics, and TTD. Data from 198 patients were analyzed. All had stage IV cancer, the median age was 65, and 55% were men. There was no significant association between Symptom burden and age, gender, or cancer site. TTD was significantly associated with TSDS ( P = 0.001) and PHS ( P = 0.001) but not with PSS ( P = 1.0). Individual Symptoms most strongly associated with TTD were lack of appetite ( P = 0.001), drowsiness ( P = 0.006), dyspnea ( P = 0.009), and fatigue ( P = 0.01). There was no significant association between TTD and anxiety ( P = 1.0) or depression ( P = 1.0). Lack of appetite, drowsiness, dyspnea and fatigue represent a cluster of Symptoms that tend to intensify at the end of life. The lack of intensification of Psychological Symptoms in relation to time to death is striking and needs to be further investigated using specific validated measures for depression and anxiety.
Katharina Voigt - One of the best experts on this subject based on the ideXlab platform.
-
development and validation of the somatic Symptom disorder b criteria scale ssd 12
Psychosomatic Medicine, 2016Co-Authors: Annekristin Toussaint, Benjamin Gierk, Katharina Voigt, Annabel Herzog, Alexandra M. Murray, Kurt Kroenke, Winfried Rief, Peter Henningsen, Bernd LöweAbstract:To develop and validate a new self-report questionnaire for the assessment of the Psychological features of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition somatic Symptom disorder.The Somatic Symptom Disorder-B Criteria Scale (SSD-12) was developed in several steps from an initial pool of 98 items. The SSD-12 is composed of 12 items; each of the three Psychological subcriteria is measured by four items. In a cross-sectional study, the SSD-12 was administered to 698 patients (65.8% female, mean [standard deviation] age = 38.79 [14.15] years) from a psychosomatic outpatient clinic. Item and scale characteristics as well as measures of reliability and validity were determined.The SSD-12 has good item characteristics and excellent reliability (Cronbach α =.95). Confirmatory factor analyses suggested that a three-factorial structure that reflects the three Psychological criteria interpreted as cognitive, affective, and behavioral aspects (n = 663, Comparative Fit Index > 0.99, Tucker-Lewis Index > 0.99, Root Mean Square Error of Approximation = 0.06, 90% confidence interval = 0.01-0.08). SSD-12 total sum score was significantly associated with somatic Symptom burden (r = 0.47, p <.001) and health anxiety (r = 0.71, p <.001), and moderately associated with general anxiety (r = 0.35, p <.001) and depressive Symptoms (r = 0.22, p <.001). Patients with a higher SSD-12 Psychological Symptom burden reported higher general physical and mental health impairment and significantly higher health care use.The SSD-12 is the first self-report questionnaire that operationalizes the new Psychological characteristics of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition somatic Symptom disorder. Initial assessment indicates that the SSD-12 has sufficient reliability and validity to warrant further testing in both research and clinical settings.
-
towards positive diagnostic criteria a systematic review of somatoform disorder diagnoses and suggestions for future classification
Journal of Psychosomatic Research, 2010Co-Authors: Katharina Voigt, Annabel Nagel, Bjorn Meyer, Gernot Langs, Christoph Braukhaus, Bernd LöweAbstract:Abstract Objectives The classification of somatoform disorders is currently being revised in order to improve its validity for the DSM-V and ICD-11 . In this article, we compare the validity and clinical utility of current and several new diagnostic proposals of those somatoform disorders that focus on medically unexplained somatic Symptoms. Methods We searched the Medline, PsycInfo, and Cochrane databases, as well as relevant reference lists. We included review papers and original articles on the subject of somatoform classification in general, subtypes of validity of the diagnoses, or single diagnostic criteria. Results Of all diagnostic proposals, only complex somatic Symptom disorder and the Conceptual Issues in Somatoform and Similar Disorders (CISSD) example criteria reflect all dimensions of current biopsychosocial models of somatization ( construct validity ) and go beyond somatic Symptom counts by including Psychological and behavioral Symptoms that are specific to somatization ( descriptive validity ). Predictive validity of most of the diagnostic proposals has not yet been investigated. However, the number of somatic Symptoms has been found to be a strong predictor of disability. Some evidence indicates that Psychological Symptoms can predict disease course and treatment outcome (e.g., therapeutic modification of catastrophizing is associated with positive outcome). Lengthy Symptom lists, the requirement of lifetime Symptom report (as in abridged somatization), complicated Symptom patterns (as in current somatization disorder), and imprecise definitions of diagnostic procedures (e.g., missing Symptom threshold in complex somatic Symptom disorder) reduce clinical utility . Conclusion Results from the reviewed studies suggest that, of all current and new diagnostic suggestions, complex somatic Symptom disorder and the CISSD definition appear to have advantages regarding validity and clinical utility. The integration of Psychological and behavioral criteria could enhance construct and descriptive validity, and confers prospectively relevant treatment implications. The incorporation of a dimensional approach that reflects both somatic and Psychological Symptom severity also has the potential to improve predictive validity and clinical utility.
Maria Browall - One of the best experts on this subject based on the ideXlab platform.
-
validity and reliability of the swedish version of the memorial Symptom assessment scale msas an instrument for the evaluation of Symptom prevalence characteristics and distress
Journal of Pain and Symptom Management, 2013Co-Authors: Maria Browall, Elisabeth Kenne Sarenmalm, Salmir Nasic, Yvonne Wengstrom, Fannie GastonjohanssonAbstract:Abstract Context There are few scales in Swedish that assess Symptoms in the dimensions of frequency, severity, and distress. Objectives The purpose of this study was to translate and determine the validity and reliability of the Memorial Symptom Assessment Scale (MSAS) in a Swedish population of postmenopausal women newly diagnosed with primary or recurrent breast cancer. Methods The original 32-item MSAS, a self-report measure for assessing Symptom distress and frequency in cancer patients, was translated and administered to 206 patients (primary, n = 150 and recurrent, n = 56). Results The MSAS Psychological Symptom subscale correlated with the emotional and cognitive functioning subscales of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and showed the highest correlation with the EORTC QLQ-C30 emotional functioning subscale (r = −0.78; P Conclusion The Swedish version of the MSAS presents as a valid and reliable measure for assessing Symptom distress, severity, and frequency in Swedish patients diagnosed with primary and recurrent breast cancer.